Concourse Financial Group Securities, Inc. Chemomab Therapeutics Ltd. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CMMB
# of Institutions
10Shares Held
3.59MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY1.61MShares$4.31 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA941KShares$2.51 Million0.04% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3738KShares$1.97 Million0.24% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$568,8480.08% of portfolio
-
Kestra Private Wealth Services, LLC31.2KShares$83,4130.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $30.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...